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Abstract
Introduction 
Screening for colorectal cancer can reduce incidence and death, but screening is underused, especially among 
vulnerable groups such as Medicaid patients. Effective interventions are needed to increase screening frequency. Our 
study consisted of a controlled trial of an intervention designed to improve colorectal cancer screening among Medicaid 
patients in North Carolina.
Methods 
The intervention included a mailed screening reminder letter and decision aid followed by telephone support from an 
offsite, Medicaid-based, patient navigator. The study included 12 clinical practices, 6 as intervention practices and 6 as 
matched controls. Eligible patients were aged 50 years or older, covered by Medicaid, and identified from Medicaid 
claims data as not current with colorectal cancer screening recommendations. We reviewed Medicaid claims data at 6 
months and conducted multivariate logistic regression to compare participant screening in intervention practices with 
participants in control practices. We controlled for sociodemographic characteristics.
Results 
Most of the sample was black (53.1%) and female (57.2%); the average age was 56.5 years. On the basis of Medicaid 
claims, 9.2% of intervention participants (n = 22/240) had had a colorectal cancer screening at the 6-month review, 
compared with 7.5% of control patients (n = 13/174). The adjusted odds ratio when controlling for age, comorbidities, 
race, sex, and continuous Medicaid eligibility was 1.44 (95% confidence interval, 0.68–3.06). The patient navigator 
reached 44 participants (27.6%).
Conclusion 
The intervention had limited reach and little effect after 6 months on the number of participants screened. Higher-
intensity interventions, such as use of practice-based navigators, may be needed to reach and improve screening rates in 
vulnerable populations.
Introduction
Colorectal cancer (CRC) screening is effective at reducing both CRC incidence and mortality (1) but is underused; only 
65.4% of age-eligible US adults were current with screening guidelines in 2010 (2). Screening is lower for Medicaid 
recipients (55.4%) compared with privately insured people (69.8%) both nationally and in North Carolina (3–5).
Effective interventions for increasing CRC screening exist (6), but it is unlikely that any single intervention can address 
the multiple screening barriers encountered at the patient, provider, clinic, and system levels. For example, mailed 
screening reminders and decision aids are an effective, low-cost, high-reach approach for increasing intention to obtain 
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CRC screening (7,8), but reminders do not address barriers that arise after a person has decided to get screened. Patient 
navigation can both address individual-level screening barriers and help patients overcome clinical practice and system-
level barriers. Patient navigation may also be particularly useful at increasing screening among vulnerable groups (9–
11); however, navigation services can be limited by low percentage of populations reached and high cost. Interventions 
employing multiple methods that combine high-reach, modest-efficacy interventions (ie, mailed reminders or decision 
aids) with targeted use of higher-efficacy, higher-cost interventions (ie, patient navigation) may increase screening of 
vulnerable groups and direct more costly care to patients with significant barriers to screening. Additionally, these 
interventions may be more effective if they can be implemented by insurers and quality-improvement organizations.
In our study, we tested a combined intervention consisting of a mailed screening reminder and decision aid followed by 
telephone-based patient navigation. The main study objectives were to 1) determine intervention effectiveness by 
comparing CRC screening rates among patients in intervention practices with patients in matched control practices, at 6 
months and 1 year; 2) measure the reach and use of the intervention components; and 3) estimate intervention efficacy 
by examining screening rates for intervention participants who used intervention components versus those who did not.
Methods
Researchers at the University of North Carolina at Chapel Hill (UNC) conducted this study from February through 
September 2011 in partnership with Community Care of North Carolina (CCNC), a statewide, community-based system 
of managed care for Medicaid recipients that links recipients to primary care practices. Practices are organized into 14 
regional networks for coordination of quality improvement and care management activities. We worked with CCNC to 
identify regional networks that would be amenable to participation and subsequently chose Community Care of Lower 
Cape Fear (CCLCF), based in southeastern North Carolina. All study methods were approved by the institutional review 
board of UNC.
Eligibility and recruitment of practices and participants
In order to ensure heterogeneity and improve generalizability, clinical and executive leadership from CCLCF selected a 
set of 6 intervention practices that differed on the following characteristics: size, geographic region (urban vs rural), and 
whether or not the practices trained medical residents. Our goal was to select practices that together had a total of 250 
to 300 unscreened patients aged 50 to 74 years. For the purpose of selecting practices, we determined the number of 
patients who were not up-to-date for screening by using Medicaid claims as of January 1, 2011. CCLCF’s medical 
director sent the practices selected for the intervention information about the study and asked for their participation; all 
practices approached agreed to participate. We conducted meetings with leaders at the participating intervention 
practices in February and March of 2011 to familiarize them with the study and collect basic information about each 
practice. CCLCF also identified a set of 6 matched control practices that were similar to intervention practices on the 
selection criteria (size, location, medical residents) to serve as a comparison group.
The number of primary care physicians at the 6 intervention practices ranged from 1 to 17. The number of non-Medicare 
eligible Medicaid patients aged 50 to 75 years that these practices served ranged from 25 to 149; the baseline CRC 
screening rates among the intervention practices ranged from 30.0% to 52.0% (mean, 35.6%). The eligible population at 
control practices ranged from 27 to 146, and screening rates for the target population in those practices ranged from 
25.9% to 52.1% (mean = 46.0%).
Eligible patients were aged 50 to 74 years, currently enrolled in Medicaid, not enrolled in Medicare, and not currently 
meeting CRC screening recommendations (1). We determined if a patient had been screened by using Medicaid claims 
data as of the date of the practice meeting for intervention practices; the same date was used for the matched control 
practices. We requested and received a waiver of informed consent from intervention patients. We did not contact or 
enroll control patients, but received de-identified screening data compiled by CCNC on the basis of Medicaid claims.
Intervention
Approximately 2 months after the initial meeting with the clinical intervention practices, the navigator mailed all 
eligible intervention patients a packet containing a letter from their physician on the physician’s practice letterhead. For 
2 practices where policy did not allow the letter to come from the physician, the letter came from the patient navigator 
on CCLCF letterhead. The letter indicated that the patients needed to be screened for CRC and invited them to 
participate in the study. The packet contained an information sheet explaining the study, a survey, and an updated 
version of a previously tested CRC screening decision aid (12). The decision aid, called CHOICE, is an 11-minute DVD 
that provides information about colorectal cancer and the different tests that screen for this cancer. The DVD included 
testimonials from people who have been screened and a comparison of colonoscopy and the stool blood test screening 
method. The decision aid promotes screening and emphasizes that patients can choose the test that is best for them.
The mailing included an option to decline participation in data collection and any further intervention by mail or by 
telephone. The letter directed those who wished to participate to watch the decision aid DVD before completing and 
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returning the survey. It also gave participants the option to contact the patient navigator directly with any questions or 
concerns.
CCLCF leadership selected a Medicaid patient outreach coordinator from their staff to serve as the patient navigator. 
The patient navigator participated in a 2-day training that covered CRC and CRC-screening information, motivational 
interviewing techniques (13), how to work with patients at different stages of change, and how to address practical 
barriers to screening (14). We adapted training materials from previous studies (15,16). After the training, the patient 
navigator conducted several mock telephone calls; the research team monitored the calls and provided feedback.
One month after mailing the packet to intervention participants, the patient navigator made 3 attempts to call each 
patient who had not opted out of the study. She worked with the patient’s practice staff to resolve disconnected or 
nonworking telephone numbers. When a patient was reached, the navigator identified herself as a Medicaid patient 
navigator working with the patient’s physician. She confirmed that the patient had received the information packet and 
offered the patient the opportunity to complete the survey on the telephone if the patient had not already returned it by 
mail. The patient navigator then offered her assistance to anyone except those who opted out, were determined 
ineligible because of recent screening, or were unable to communicate in English. She assessed the participants’ stages 
of change and used motivational interviewing techniques to encourage screening and make a decision about whether or 
not to get screening and screening type. She helped participants address barriers, assisted with scheduling and 
transportation, called to remind participants about appointments, and ensured that patients completed the preparation 
and testing properly. The patient navigator attempted to follow up with patients until the 6-month intervention period 
ended or the patient declined further contact.
Data collection
We used North Carolina Medicaid claims data to identify all Medicaid patients at participating clinical practices who 
were not up-to-date with CRC screening at baseline. We queried the claims data for both intervention and control 
patients to identify any CRC screenings that occurred within the 6-month intervention period, and we made identical 
queries at 1 year. We used Medicaid records to collect data on sex, age, race, and co-morbidities and to determine 
whether the patient had been enrolled in Medicaid continuously throughout the study period or if they had become 
eligible for Medicare during that period.
A trained CCNC care manager who was not a member of the study team conducted chart reviews for intervention 
patients. The chart review looked for evidence of any discussion, ordering, or completion of a CRC screening test during 
the intervention period, the date of the test if it had been completed, and the dates of all primary care visits during the 
intervention period.
We included the participant survey in the initial packet mailed to intervention participants; the letter asked interested 
participants to complete the survey after watching the DVD. Participants who did not return the survey by mail had the 
option to complete it over the telephone with the navigator. We mailed anyone who completed the survey a $10 gift 
card. The survey included questions on screening history, screening intentions, patient and family history related to 
CRC and other risk factors, demographics, and the participant’s opinions about the DVD decision aid.
Assessing study outcomes
We used Medicaid claims to determine whether or not a participant had completed any CRC screening test during the 6-
month intervention period for intervention and control patients who were eligible for the intervention on the basis of 
claims data only. We also added a secondary outcome of completion of a CRC screening test at 12 months to account for 
delays in screening test completion and Medicaid claims processing. For this intention-to-treat analysis, we did not 
exclude anyone from the intervention group so that the sample would be most similar to the matched controls who had 
no option to opt out or self-report as ineligible.
We examined intervention reach by determining the percentage of intervention participants who received or used the 
different components of the intervention. We measured decision aid use by using responses to questions on the 
participant survey. We determined contact with the patient navigator based on the telephone logs the navigator kept.
To estimate the efficacy of individual intervention components, we compared screening odds for participants who 
received each intervention component with those who did not. For this analysis, we excluded participants who were not 
eligible for the study because they were up-to-date for screening at baseline (determined by either chart review or 
Medicaid claims data) or who opted out or self-reported as ineligible. We considered participants to have received a 
screening during the intervention period if the screening was reported in either the Medicaid claims or chart review 
data.
Analyses
We completed all analyses with SAS Version 9.2 (SAS Institute, Inc, Cary, North Carolina) and used statistical 
procedures to account for patient clustering within practices. We used Rao-Scott χ  to test differences in categorical 2
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variables between intervention and control groups and between subgroups. To compare screening between intervention 
and control patients, we used multivariate logistic regression including fixed-effect terms for experimental condition 
and to adjust for clustering within practices and potential confounders. For the adjusted analysis, we excluded 
intervention patients who opted out of the study (n = 27) because covariate data were not available for this group.
Results
Participant characteristics
On the basis of the initial review of Medicaid claims, 242 patients at intervention practices were eligible for the study 
(Figure). Of patients at control practices, 174 were eligible for the study. Of this initial sample, 57.2% were female, and 
average age was 56.5 years; 98.3% were aged less than 65 years (Table 1). Race differed between groups: 62.0% of 
intervention participants were black compared with 40.8% of control participants. On the basis of chart reviews, 83.7% 
of participants had at least 1 visit to the physician practice during the intervention period; the average of number of 
visits was 1.9 (95% CI: 1.6–2.2).
Figure. Selection of eligible patients from intervention practices to study the reach, usage, and effectiveness of a 
Medicaid patient navigator intervention to increase colorectal cancer screening, Cape Fear, North Carolina, 2011. 
Medicaid claims data used for comparison with controls was missing for 2 participants; for that analysis n = 240. [A text 
description of this figure is also available.]
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Intervention effectiveness
Medicaid claims data were missing at follow-up for 2 of the initial 242-person sample of intervention participants, 
leaving 240. Medicaid claims data showed that 9.2% of intervention participants (n = 22), had a CRC screening test 
during the 6-month intervention period compared with 7.5% of control participants (n = 13; unadjusted odds ratio 
[OR], 1.25; 95% confidence interval [CI], 0.63–2.50). After controlling for age, comorbidities, race, sex, and continuous 
Medicaid eligibility, the adjusted OR was 1.44 (95% CI, 0.68–3.06). Claims data were reviewed again at 1 year, and we 
found that 16.3% of intervention participants had been screened compared with 10.3% of control patients. Screening 
was still not significantly higher in the intervention group (unadjusted OR, 1.68; 95% CI, 0.80–3.56).
Intervention reach, use, and efficacy
All of the 242 intervention patients that we originally categorized as unscreened on the basis of Medicaid claims data 
were offered the intervention, however for the purpose of determining intervention efficacy, we excluded anyone from 
the analysis who opted out of the study (n = 27), did not meet eligibility criteria (n = 31), or whose chart review 
indicated previous CRC screening (n = 21), resulting in 163 eligible intervention participants (Figure). The overall 
screening rate within this group considering both claims and chart review data was 12.9% (21/163) (Table 2).
Among the 163 intervention participants with complete data from both sources, 56 people (34.4%) completed the survey 
(Table 2). Participants who completed the survey had greater odds of being screened at follow-up (OR, 4.4, 95% CI: 1.4–
13.9). The survey asked participants if they had watched the decision aid; 42 of 56 participants who completed the 
survey responded to this question. Among those who answered the question, 50% indicated that they had watched some 
or all of the decision aid. The odds of getting screened was higher for those reported watching some or all of the decision 
aid compared with those who did not watch it (OR, 1.4; 95% CI, 0.4–5.7), but these differences were not significant.
The patient navigator was able to reach 44 (27.6%) participants. Over half of 242 intervention patients that we 
attempted to contact were not reached because of wrong or disconnected numbers (n = 59) or because they failed to 
answer after 3 telephone call attempts (n = 69). The odds of getting screened were higher for those who were reached 
versus those who were not (OR, 3.5; 95% CI, 1.7–7.1). Among patients with chart review data (n=142), we found that 
only 16.2% (n = 23) of patients had no reported provider visits during the intervention period. The odds of getting 
screened were not significantly higher among patients who had a visit during the study period compared with those who 
did not (OR, 3.5; 95% CI, 0.8–15.0).
Comparison of charts and claims data
Medicaid claims data indicated that 8.7% (n = 16) of eligible intervention patients who did not refuse participation (n = 
184) were screened during the 6-month intervention period (Table 3). For the chart-review only analysis, we looked at 
participants (n=142/184) who were unscreened at baseline based on their chart reviews; we excluded anyone for whom 
chart review data was unavailable (n = 21) or who was up-to-date with CRC screening at baseline based on the chart 
review (n = 21). Similarly, data indicated that 8.5% (12/142) had been screened on the basis of chart review data only. 
Combining the data from both sources yielded a higher screening rate of 12.9% (21/163). Among those who had a visit, 
but were not screened during the intervention period (n = 130), 30 additional patient charts showed that CRC screening 
had either been discussed or ordered (23.1%).
Process outcomes
Among intervention participants who completed a survey (n = 56), most (51%) said that they were definitely interested 
in getting screened in the next 6 months and that they intended to ask for screening (60%). Colonoscopy, the preferred 
test, was selected by 35% of respondents; 27% preferred fecal occult blood test only, 10% preferred sigmoidoscopy alone 
or with fecal occult blood test, 25% were unsure, and 4% did not intend to get screened. Among survey respondents who 
answered the question about DVD ownership, 62% (30/48) reported having a DVD player at home. Among the 21 
respondents who reported watching the DVD decision aid, most stated that the amount of information included was 
“about right” (13/21, 61.9%), that the information “was not upsetting” (66.6%), that the length was “just about 
right” (71.4%), that all of the information provided was clear (61.9%), that it was very helpful for making a decision 
(64%), and that they would recommend the decision aid (61.9%).
Discussion
We found that our mailed DVD decision aid and telephone-based patient navigator intervention did not significantly 
increase CRC screening among Medicaid patients compared with matched controls. Our results differ from those of 
previous patient navigator interventions, which showed improvements in screening in vulnerable groups (9,10,16,17). 
Two studies used telephone-based counseling but included only those who agreed to participate in the final analysis 
(16,17). For our intent-to-treat analysis, we included all eligible participants so that we could estimate the effect of the 
intervention in the full eligible population, not just the subgroup that would agree to participate in a study.
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In studies with similar methods, patient navigators reached 44.0% to 75.0% of patients compared with 26.7% in our 
study. Our navigator was unable to contact most patients over the telephone because of wrong or disconnected numbers 
and unanswered calls. Including in-person recruitment (9) and increasing the number and length of contacts (10) may 
have improved our reach. As was found in previous research, we found that screening was higher among participants 
who talked with the patient navigator (9,10). However, even those whom the navigator reached did not fully use the 
patient navigator’s services. Anecdotally, we found that many patients did not think they needed help or preferred to 
speak with their physician before making a decision.
Our study had some limitations. It was not randomized, but did use a matched control group. We controlled for 
demographic differences in our analysis to account for differential distribution of demographic characteristics, notably 
race, between groups. One limitation of using data from control practices whose patients were not enrolled in the study 
was that only claims data and not chart review data were available for the control group. Thus, we based the 
effectiveness analysis only on claims, which may have missed some screening, particularly through fecal occult blood 
testing, which is not always billed. We also included people who may have already been screened, which potentially led 
to underestimation of outcome estimates.
This study has several strengths. We targeted a vulnerable population with substantial comorbidities and socioeconomic 
barriers to screening. We also conducted the study in partnership with CCNC, which allowed us to better understand 
how similar programs could be integrated into the current health care infrastructure and possibly disseminated across 
the state.
Because contacting patients was difficult, future studies could increase intervention reach and use by basing the work in 
a clinical setting. Previous studies using decision aids and health educators playing a similar role to a navigator have 
been effectively delivered in a clinic setting (18,19). Moreover, most (84.3%) of patients in our study had at least 1 visit 
during the 6-month study period, suggesting potential opportunities to meet the navigator in the clinic, establish 
rapport, and project stronger physician endorsement of the intervention. Our results suggest that if reach and use were 
improved, the decision aid plus patient navigator intervention could increase CRC screening among vulnerable patients.
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Tables 
 
Table 1. Baseline Characteristics of Intervention and Control Patients Using 
Medicaid Data, Intervention to Increase Colorectal Cancer Screening, North 
Carolina, 2011
Characteristic
Entire Sample(N = 
416), N (%)
Intervention (n = 
242), %
Control, 
%
P 
Value
Female 238 (57.2) 57.0 57.5 .09
Age, y
50–54 167 (40.1) 39.7 40.8
.87
55–59 132 (31.7) 31.8 31.6
60–64 110 (26.4) 26.4 26.4
≥65 7 (1.7) 2.1 1.1
Race
Black 221 (53.1) 62.0 40.8
<.001
White 167 (40.1) 31.0 52.9
a
a
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Characteristic
Entire Sample(N = 
416), N (%)
Intervention (n = 
242), %
Control, 
%
P 
Value
Other 4 (1.0) 0.41 1.7
Unreported 24 (5.8) 6.6 4.6
Became eligible for Medicare during 
study
19 (4.5) 15.6 2.9 .10
Had continuous Medicaid eligibility 
during study
378 (89.4) 88.8 90.2 .67
Age, y, mean (SE) 56.5 (0.38) 56.5 (0.34) 56.2 
(0.26)
.52
Comorbidities score , mean (SE) 3.9 (0.30) 3.5 (0.22) 4.4 (0.41) .02
 All data in table are from Medicaid records and are n (%) unless otherwise indicated. 
 P value comparing intervention versus control participants calculated by using Rao-Scott χ  test adjusted for cluster 
randomized design (categorical variables) or t tests for continuous variables. 
 Other races include Native Hawaiian/Pacific Islander, Asian, and American Indian/Alaska Native. 
 The comorbidities score is from Medicaid’s Clinical Risk Group weighting system 
(http://www.ncbi.nlm.nih.gov/pubmed/14713742), which assigns scores to patients on the basis of a prediction of resources 
needed to address their conditions. For example, a weight of 3 indicates that a patient is expected to spend 3 times the time 
of the average patient.
 
Table 2. Colorectal Cancer Screening Outcomes at 6 Months for Intervention 
Participants According to Intervention Exposure, Intervention to Increase 
Colorectal Cancer Screening, North Carolina, 2011
Process Variable Reach Any Screening During Study , P Value
n (%) % (95% Confidence Interval )
Eligible intervention participants 163 (100) 12.9 (NA) (NA)
Completed the survey
Yes 56 (34.4) 23.2 (16.6–29.8)
.004
No 107 (65.6) 7.5 (0-15.8)
Watched decision aid (survey completers only )
Some or all 21 (50.0) 28.6 (10.4–46.7)
.31
No 21 (50.0) 19.0 (3.0–35.0)
Spoke with patient navigator
Yes 45 (27.6) 22.2 (11.7–32.7)
<.001
No 118 (72.4) 9.3 (3.8–14.8)
Had follow-up call (among those who spoke with patient navigator)
Yes 26 (57.8) 30.8 (12.1–49.4)
.12
No 19 (42.2) 6.6 (0-27.6)
Had physician visit during study period (among patients with chart reviews only )
Yes 118 (84.3) 14.4 (8.1–20.7)
.10
No 23 (16.3) 4.3 (0.0–12.0)
Abbreviation: NA, not applicable. 
 Table includes only participants who did not refuse and were not up-to-date for screening at baseline on the basis of self-
report, Medicaid claims data, or chart review data (n = 163). For this analysis we looked at only the 163 (out of the initial 
242) intervention participants who met all eligibility criteria based on both chart review and Medicaid claims data. We 
excluded 27 people who opted out of the study, 31 people who self-reported as ineligible, and 21 people who were 
a
c
d
a
b 2
c
d
a
b c
c
d
e
a
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determined to be retroactively ineligible because their chart review indicated that they had had been up-to-date with CRC 
screening at baseline. 
 Includes evidence or screening during the intervention period found in chart reviews or Medicaid claims data. 
 P values and 95% confidence intervals are calculated by using χ  test and account for clustering by practice 
 Excludes people who answered the survey, but skipped the decision aid questions (n = 14). 
 Excludes 2 patients for whom data on visits was missing on their chart review (n=141)
 
Table 3. Colorectal Cancer Screening Outcomes at 6 Months for Intervention 
Participants Based on Chart or Medicaid Claims Data, Intervention to 
Increase Colorectal Cancer Screening, North Carolina, 2011
Colorectal Cancer 
Screening
Medicaid Claims Only 
(n = 184), N (%)
Chart Review Only
(n = 142), N (%)
Combined Medicaid Claims and Chart 
Review Data  (n = 163), N (%)
Any screening during 
study
16 (8.7) 12 (8.5) 21 (12.9)
Colonoscopy during 
study
11 (6.0) 9 (6.3) 14 (8.6)
Fecal occult blood test 
during study
13 (7.1) 3 (2.1) 16 (9.8)
 Table includes only intervention participants who did not refuse to be in the study and did not self-report as ineligible (n = 
184). 
 Chart review only excludes anyone for whom chart review data were unavailable (n = 21) or who was up-to-date with CRC 
screening at baseline based on the chart review (n = 21). 
 Combined data excludes participants who were up-to-date with screening at baseline based on Medicaid claims data or 
chart reviews. Evidence of screening during the intervention is accepted from either source (chart reviews or Medicaid 
claims).
 
The opinions expressed by authors contributing to this journal do not necessarily reflect the opinions of the U.S. 
Department of Health and Human Services, the Public Health Service, the Centers for Disease Control and Prevention, or 
the authors' affiliated institutions. 
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